Topical niclosamide (ATx201) reduces <i>Staphylococcus aureus</i> colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trialAnne Weiss, Morten Otto Alexander Sommer|Clinical and Translational Medicine|2022Cited by 46